Virion Biotherapeutics is focused on developing therapeutic interfering particles (TIPs) for the treatment of respiratory viral infections
Virion Biotherapeutics is focused on developing therapeutic interfering particles (TIPs) for the treatment of respiratory viral infections. Their lead product, VH244, has shown promise in preclinical studies for reducing viral replication and preventing disease in models of respiratory syncytial virus.